The Trump administration has reached an agreement with researchers and Democratic-led states who filed a lawsuit over cuts to diversity-related research funding at the National Institutes of Health (NIH). The deal, announced Monday, allows stalled or rejected grant applications to move forward for review after months of legal uncertainty surrounding diversity, equity, and inclusion (DEI) research funding.
The dispute began after the NIH canceled hundreds of millions of dollars in research grants, citing concerns that the projects were tied to DEI initiatives rather than core scientific objectives. In response, affected researchers and states sued the federal government, arguing that the funding cuts were unlawful and arbitrary. Earlier this year, U.S. District Judge William Young ruled in Boston that the NIH had improperly terminated the grants, finding that the cancellations violated federal law.
However, the legal battle became more complex in August when the U.S. Supreme Court partially paused Judge Young’s ruling. The high court determined that claims related to the terminated grants should be heard by a specialized federal court that handles monetary disputes with the government. At the same time, the Supreme Court left unresolved a separate issue regarding how the NIH handled applications for future research funding.
Monday’s agreement addresses that unresolved portion of the case. Under the deal, the federal government has agreed to conduct new reviews of grant applications that were frozen, denied, or withdrawn after the policy change was announced. Importantly, the agreement does not require the NIH to approve or fund any specific research proposals, but it does reopen the door for fair consideration.
The researchers involved say the affected grants cover critical public health areas, including HIV prevention, Alzheimer’s disease, LGBTQ health, and sexual violence research. One of the plaintiffs, Nikki Maphis, a postdoctoral researcher at the University of New Mexico, welcomed the development, saying it allows her Alzheimer’s and aging brain research to move forward after what she described as an “arbitrary and destructive freeze.”
The agreement does not affect Judge Young’s earlier ruling blocking the NIH policy itself. The U.S. Department of Health and Human Services has appealed that decision and maintains that it ended funding for research it believes prioritized ideology over scientific rigor.


Najib Razak Seeks Stay of 15-Year 1MDB Prison Sentence
FAA Allows Boeing to Sell 35 More 777F Freighters Beyond 2028
US Resumes Immigrant Visa Processing for Hungary, Poland
Amazon Shares Fall as FTC Plans Ad Pricing Lawsuit
US Backs Musk in Fight Against EU’s €120 Million X Fine
Trump Administration Removes Confederate Memorial Criticism From Arlington Website
Maduro Seeks Dismissal of US Drug Trafficking Charges
Netanyahu’s Brief US Trip Highlights Strains With Trump
Najib Razak Granted House Arrest Until 2028
US Court Approves airBaltic Chapter 11 Restructuring
Trump Scales Back Endangered Species Act Protections
Trump Asks Supreme Court to Restore Third-Country Deportations
Trump Bans CNN, MS NOW and Politico From White House
Nvidia-Groq AI Chip Deal Faces U.S. Antitrust Probe
OpenAI Rejects Apple Trade Secret Theft Claims
NATO Boosts Intelligence Sharing Amid Russia Hybrid Threats
Abbas Reaffirms November 28 Palestinian Elections 



